Magnetic resonance imaging in patients with temporary external pacemakers

Daniel Benjamin Fyenbo; Morten Steen Kvistholm Jensen; Mads Brix Kronborg; Jens Kristensen; Jens Cosedis Nielsen; Christoffer Tobias Witt

doi:10.1093/europace/euac147

Magnetic resonance imaging in patients with temporary external pacemakers

Daniel Benjamin Fyenbo^*, Morten Steen Kvistholm Jensen, Mads Brix Kronborg, Jens Kristensen, Jens Cosedis Nielsen, Christoffer Tobias Witt

^*Corresponding author for this work

Department of Clinical Medicine - The Department of Cardiological Medicine B

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

2 Citations (Scopus)

Abstract

Aims To describe safety and feasibility of magnetic resonance imaging (MRI) in patients with transvenous temporary external pacemakers and whether artefacts affect the diagnostic image quality during cardiac MRI. Methods and We reviewed records of all patients treated with temporary external pacing between 2016 and 2020 at a tertiary centre results Temporary pacing was established using a transvenous standard active fixation pacing lead inserted percutaneously and connected to a MRI-conditional pacemaker taped to the skin. All patients undergoing cardiac or non-cardiac MRI during temporary transvenous pacing were identified. Before MRI, devices were programmed according to guidelines for per manent pacemakers, and patients were monitored with continuous electrocardiogram during MRI. Of 827 consecutive patients receiving a temporary external pacemaker, a total of 44 (5%) patients underwent MRI (mean age 71 years, 13 [30%] females). Cardiac MRI was performed in 22 (50%) patients, while MRI of cerebrum, spine, and other regions was performed in the remaining patients. Median time from implantation of the temporary device to MRI was 6 (3–11) days During MRI, we observed no device-related malfunction or arrhythmia. Nor did we detect any change in lead sensing impedance, or pacing threshold. We observed no artefacts from the lead or pacemaker compromising the diagnostic image quality of cardiac MRI. MRI provided information to guide the clinical management in all cases. Conclusion MRI is feasible and safe in patients with temporary external pacing established with a regular MRI-conditional pacemaker and a standard active fixation lead. No artefacts compromised the diagnostic image quality.

Original language	English
Journal	Europace
Volume	24
Issue	12
Pages (from-to)	1960-1966
Number of pages	7
ISSN	1099-5129
DOIs	https://doi.org/10.1093/europace/euac147
Publication status	Published - 1 Dec 2022

Keywords

Aged
Arrhythmias, Cardiac/diagnostic imaging
Artifacts
Electrocardiography
Female
Humans
Magnetic Resonance Imaging/methods
Male
Pacemaker, Artificial/adverse effects

Access to Document

10.1093/europace/euac147

Cite this

@article{217943161fc646cb80d277ee96ede11a,

title = "Magnetic resonance imaging in patients with temporary external pacemakers",

abstract = "Aims To describe safety and feasibility of magnetic resonance imaging (MRI) in patients with transvenous temporary external pacemakers and whether artefacts affect the diagnostic image quality during cardiac MRI. Methods and We reviewed records of all patients treated with temporary external pacing between 2016 and 2020 at a tertiary centre results Temporary pacing was established using a transvenous standard active fixation pacing lead inserted percutaneously and connected to a MRI-conditional pacemaker taped to the skin. All patients undergoing cardiac or non-cardiac MRI during temporary transvenous pacing were identified. Before MRI, devices were programmed according to guidelines for per manent pacemakers, and patients were monitored with continuous electrocardiogram during MRI. Of 827 consecutive patients receiving a temporary external pacemaker, a total of 44 (5%) patients underwent MRI (mean age 71 years, 13 [30%] females). Cardiac MRI was performed in 22 (50%) patients, while MRI of cerebrum, spine, and other regions was performed in the remaining patients. Median time from implantation of the temporary device to MRI was 6 (3–11) days During MRI, we observed no device-related malfunction or arrhythmia. Nor did we detect any change in lead sensing impedance, or pacing threshold. We observed no artefacts from the lead or pacemaker compromising the diagnostic image quality of cardiac MRI. MRI provided information to guide the clinical management in all cases. Conclusion MRI is feasible and safe in patients with temporary external pacing established with a regular MRI-conditional pacemaker and a standard active fixation lead. No artefacts compromised the diagnostic image quality.",

keywords = "Aged, Arrhythmias, Cardiac/diagnostic imaging, Artifacts, Electrocardiography, Female, Humans, Magnetic Resonance Imaging/methods, Male, Pacemaker, Artificial/adverse effects",

author = "Fyenbo, {Daniel Benjamin} and Jensen, {Morten Steen Kvistholm} and Kronborg, {Mads Brix} and Jens Kristensen and Nielsen, {Jens Cosedis} and Witt, {Christoffer Tobias}",

note = "{\textcopyright} The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please email: [email protected].",

year = "2022",

month = dec,

day = "1",

doi = "10.1093/europace/euac147",

language = "English",

volume = "24",

pages = "1960--1966",

journal = "Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "12",

}

TY - JOUR

T1 - Magnetic resonance imaging in patients with temporary external pacemakers

AU - Fyenbo, Daniel Benjamin

AU - Jensen, Morten Steen Kvistholm

AU - Kronborg, Mads Brix

AU - Kristensen, Jens

AU - Nielsen, Jens Cosedis

AU - Witt, Christoffer Tobias

PY - 2022/12/1

Y1 - 2022/12/1

N2 - Aims To describe safety and feasibility of magnetic resonance imaging (MRI) in patients with transvenous temporary external pacemakers and whether artefacts affect the diagnostic image quality during cardiac MRI. Methods and We reviewed records of all patients treated with temporary external pacing between 2016 and 2020 at a tertiary centre results Temporary pacing was established using a transvenous standard active fixation pacing lead inserted percutaneously and connected to a MRI-conditional pacemaker taped to the skin. All patients undergoing cardiac or non-cardiac MRI during temporary transvenous pacing were identified. Before MRI, devices were programmed according to guidelines for per manent pacemakers, and patients were monitored with continuous electrocardiogram during MRI. Of 827 consecutive patients receiving a temporary external pacemaker, a total of 44 (5%) patients underwent MRI (mean age 71 years, 13 [30%] females). Cardiac MRI was performed in 22 (50%) patients, while MRI of cerebrum, spine, and other regions was performed in the remaining patients. Median time from implantation of the temporary device to MRI was 6 (3–11) days During MRI, we observed no device-related malfunction or arrhythmia. Nor did we detect any change in lead sensing impedance, or pacing threshold. We observed no artefacts from the lead or pacemaker compromising the diagnostic image quality of cardiac MRI. MRI provided information to guide the clinical management in all cases. Conclusion MRI is feasible and safe in patients with temporary external pacing established with a regular MRI-conditional pacemaker and a standard active fixation lead. No artefacts compromised the diagnostic image quality.

AB - Aims To describe safety and feasibility of magnetic resonance imaging (MRI) in patients with transvenous temporary external pacemakers and whether artefacts affect the diagnostic image quality during cardiac MRI. Methods and We reviewed records of all patients treated with temporary external pacing between 2016 and 2020 at a tertiary centre results Temporary pacing was established using a transvenous standard active fixation pacing lead inserted percutaneously and connected to a MRI-conditional pacemaker taped to the skin. All patients undergoing cardiac or non-cardiac MRI during temporary transvenous pacing were identified. Before MRI, devices were programmed according to guidelines for per manent pacemakers, and patients were monitored with continuous electrocardiogram during MRI. Of 827 consecutive patients receiving a temporary external pacemaker, a total of 44 (5%) patients underwent MRI (mean age 71 years, 13 [30%] females). Cardiac MRI was performed in 22 (50%) patients, while MRI of cerebrum, spine, and other regions was performed in the remaining patients. Median time from implantation of the temporary device to MRI was 6 (3–11) days During MRI, we observed no device-related malfunction or arrhythmia. Nor did we detect any change in lead sensing impedance, or pacing threshold. We observed no artefacts from the lead or pacemaker compromising the diagnostic image quality of cardiac MRI. MRI provided information to guide the clinical management in all cases. Conclusion MRI is feasible and safe in patients with temporary external pacing established with a regular MRI-conditional pacemaker and a standard active fixation lead. No artefacts compromised the diagnostic image quality.

KW - Aged

KW - Arrhythmias, Cardiac/diagnostic imaging

KW - Artifacts

KW - Electrocardiography

KW - Female

KW - Humans

KW - Magnetic Resonance Imaging/methods

KW - Male

KW - Pacemaker, Artificial/adverse effects

UR - http://www.scopus.com/inward/record.url?scp=85168321885&partnerID=8YFLogxK

U2 - 10.1093/europace/euac147

DO - 10.1093/europace/euac147

M3 - Journal article

C2 - 36006800

SN - 1099-5129

VL - 24

SP - 1960

EP - 1966

JO - Europace

JF - Europace

IS - 12

ER -

Magnetic resonance imaging in patients with temporary external pacemakers

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this